Scientific Program
GP217 - Reimagine DME care with Dual pathway inhibitor (Roche)
Date
13/03/2026
Hall
Meeting Room U-06
From
10:45
To
11:25
Summary
Chairperson : Mangat Dogra Moderator : Parveen Sen 1. Beyond the VEGF Barrier: Elevating Real-World Patient outcomes with Bispecific in DME : Dr.Aires Lobo 2. CLEARing the Path to Stability: Bi-specific Outcomes in Indian DME Patients : Debdulal Chakraborty 3. Panel discussion : Elevating the Goal: Is Bi-specific Inhibition the New Clinical Standard for DME!! - Suganeswari G, Vivek Dave, Purnima Sood, Vinod Aggarwal, Debdulal Chakraborty & Aires Lobo
Membership No
Name
Topic
Role
Duration
Consented
S10516
Dr.Parveen Sen
Moderator
Yes
C10922
Dr.Debdulal Chakraborty
Elevating the Goal: Is Bi-specific Inhibition the New Clinical Standard for DME!!
Panelist
C10922
Dr.Debdulal Chakraborty
CLEARing the Path to Stability: Bi-specific Outcomes in Indian DME Patients
Speaker
K11452
Dr.Vinod Kumar
Elevating the Goal: Is Bi-specific Inhibition the New Clinical Standard for DME!!
Panelist
D12385
Dr.Vivek Dave
Elevating the Goal: Is Bi-specific Inhibition the New Clinical Standard for DME!!
Panelist
Yes
D02855
Dr.Mangat Ram Dogra
Chairperson
S17390
Dr.Suganeswari Ganesan
Elevating the Goal: Is Bi-specific Inhibition the New Clinical Standard for DME!!
Panelist
S08613
Dr.Purnima Sood
Elevating the Goal: Is Bi-specific Inhibition the New Clinical Standard for DME!!
Panelist
Yes
